This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Utah Research Foundation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Margo Haygood: Innovator in Antibacterial Cyclopeptides
Introduction
Margo Haygood is a prominent inventor based in Portland, Oregon. She has made significant contributions to the field of antibacterial treatments, particularly through her innovative work on cyclopeptides. Her research focuses on addressing bacterial infections caused by Gram-negative pathogens, which are known for their resistance to many conventional antibiotics.
Latest Patents
Margo Haygood holds a patent for "Antibacterial cyclopeptides targeting acinetobacter and other gram-negative pathogens." This invention relates to cyclopeptides and methods for using these compounds to effectively treat bacterial infections. The patent highlights the potential of these cyclopeptides in combating infections caused by Gram-negative pathogens, showcasing her commitment to advancing medical science.
Career Highlights
Margo is affiliated with the University of Utah Research Foundation, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to tackling antibiotic resistance, a growing concern in the medical community. With her expertise, she is paving the way for new treatment options that could save lives.
Collaborations
Margo collaborates with notable colleagues, including Eric W. Schmidt and Bailey Miller. These partnerships enhance her research capabilities and contribute to the advancement of her projects.
Conclusion
Margo Haygood is a trailblazer in the field of antibacterial research, with a focus on innovative cyclopeptides. Her contributions are vital in the fight against antibiotic-resistant infections, and her work continues to inspire future advancements in medical treatments.